A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer.
Date
2022-09-27Author
Heer, R
Lewis, R
Vadiveloo, T
Yu, G
Mariappan, P
Cresswell, J
McGrath, J
Nabi, G
Mostafid, H
Lazarowicz, H
Kelly, J
Duncan, A
Penegar, S
Breckons, M
Wilson, L
Clark, E
Feber, A
Orozco-Leal, G
Tandogdu, Z
Taylor, E
N'Dow, J
Norrie, J
Ramsay, C
Rice, S
Vale, L
MacLennan, G
Hall, E
Type
Journal Article
Metadata
Show full item recordAbstract
PDD or WL Resection of Tumors in NMIBCIn this open-label trial, patients with intermediate- or high-risk non-muscle-invasive bladder cancer at diagnosis were randomly assigned to photodynamic diagnosis or white light-guided transurethral resection of bladder tumor. Three-year recurrence-free rates were 57.8% and 61.6% in the PDD and WL groups, respectively, with no difference in quality-adjusted life years between the treatment groups at 3 years.
Collections
Research team
Clin Trials & Stats Unit
Language
eng
Date accepted
2022-07-12
Citation
NEJM Evidence,
Publisher
Massachusetts Medical Society